41.69

1.28% -0.54

After Hours: 42.02 0.33 +0.79%

Lenz Therapeutics Inc (LENZ)

Overview News Price History Discussions Forecast

Lenz Therapeutics Inc stock is traded at $41.69, with a volume of 429.48K. It is down -1.28% in the last 24 hours and up +7.53% over the past month. LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.

Previous Close:

$42.23

Open:

$42.5

24h Volume:

429.48K

Relative Volume:

0.93

Market Cap:

$1.19B

Revenue:

Net Income/Loss:

$-69.47M

P/E Ratio:

-7.4482

EPS:

-5.5973

Net Cash Flow:

$-73.92M

1W Performance:

+2.16%

1M Performance:

+7.53%

6M Performance:

+70.86%

1Y Performance:

+93.91%

1-Day Range:

$40.99

$43.80

1-Week Range:

$39.62

$43.80

52-Week Range:

$16.54

$43.80

Lenz Therapeutics Inc Stock (LENZ) Company Profile

Name

Lenz Therapeutics Inc

Sector

Healthcare (1149)

Industry

Biotechnology (644)

Phone

858-925-7000

Address

201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH

Employee

Twitter

Next Earnings Date

Latest SEC Filings

LENZ's Discussions on Twitter

Compare LENZ with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
LENZ Lenz Therapeutics Inc	41.69	1.20B	0	-69.47M	-73.92M	-5.5973
VRTX Vertex Pharmaceuticals Inc	387.11	99.26B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	598.71	62.06B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	452.17	59.21B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	731.77	44.94B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	342.89	36.57B	3.81B	-644.79M	-669.77M	-6.24

Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-14-25	Resumed	Piper Sandler	Overweight
Mar-18-25	Initiated	TD Cowen	Buy
Sep-27-24	Initiated	Raymond James	Outperform
Aug-12-24	Initiated	H.C. Wainwright	Buy
Apr-15-24	Initiated	Leerink Partners	Outperform
Apr-15-24	Initiated	William Blair	Outperform
Apr-10-24	Initiated	Citigroup	Buy
Mar-27-24	Initiated	Piper Sandler	Overweight
Feb-23-23	Downgrade	BofA Securities	Neutral → Underperform
Feb-23-23	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Feb-23-23	Downgrade	Cowen	Outperform → Market Perform
Jan-25-23	Downgrade	BTIG Research	Buy → Neutral
Jan-18-23	Downgrade	BofA Securities	Buy → Neutral
Jan-06-23	Downgrade	BMO Capital Markets	Outperform → Market Perform
Jan-06-23	Downgrade	SVB Leerink	Outperform → Mkt Perform
Sep-15-22	Initiated	Cantor Fitzgerald	Overweight
Jun-17-22	Initiated	BMO Capital Markets	Outperform
Apr-14-22	Initiated	BTIG Research	Buy
Mar-22-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Feb-18-22	Initiated	RBC Capital Mkts	Sector Perform
Jul-20-21	Initiated	Morgan Stanley	Overweight
Jul-20-21	Initiated	SVB Leerink	Outperform

View All

Lenz Therapeutics Inc Stock (LENZ) Latest News

03:08 AM

Lenz Therapeutics stock hits 52-week high at 42.79 USD - Investing.com India

03:08 AM

Sep 17, 2025

Aug Spikes: Is BCAT stock a hidden gemTrade Performance Summary & Stock Market Timing Techniques - خودرو بانک

Sep 17, 2025

Jobs Data: What analysts say about LENZ Therapeutics Inc stock2025 Trading Recap & Daily Oversold Stock Bounce Ideas - خودرو بانک

Sep 17, 2025

Sep 16, 2025

Should you wait for a breakout in LENZ Therapeutics Inc.July 2025 Trade Ideas & Daily Technical Forecast Reports - newser.com

Sep 16, 2025

Energy Moves: Can LENZ Therapeutics Inc expand its profit marginsCEO Change & Detailed Earnings Play Strategies - خودرو بانک

Sep 16, 2025

Growth Value: Is LENZ Therapeutics Inc. a cyclical or defensive stockQuarterly Portfolio Report & High Conviction Buy Zone Alerts - خودرو بانک

Sep 16, 2025

Whale Trades: Is LENZ Therapeutics Inc. a cyclical or defensive stock2025 Fundamental Recap & Target Return Focused Picks - خودرو بانک

Sep 16, 2025

Macro Review: Can LENZ Therapeutics Inc. benefit from deglobalizationProduct Launch & Verified Momentum Stock Watchlist - خودرو بانک

Sep 16, 2025

Revenue Check: Can LENZ Therapeutics Inc grow without external fundingJuly 2025 WrapUp & Safe Capital Preservation Plans - خودرو بانک

Sep 16, 2025

Sep 15, 2025

Market Overview: Will LENZ Therapeutics Inc. benefit from government policyWeekly Volume Report & Precise Swing Trade Entry Alerts - خودرو بانک

Sep 15, 2025

Is LENZ Therapeutics Inc. forming a reversal patternJuly 2025 Recap & Community Verified Trade Signals - newser.com

Sep 15, 2025

Stock Market Recap: Can LENZ Therapeutics Inc reach all time highs this yearQuarterly Performance Summary & Stock Timing and Entry Methods - خودرو بانک

Sep 15, 2025

Levels Update: What are LENZ Therapeutics Incs earnings expectationsMarket Growth Review & Real-Time Buy Signal Notifications - خودرو بانک

Sep 15, 2025

Retail Trends: Is LENZ Therapeutics Inc benefiting from interest rate changesWeekly Profit Analysis & Reliable Momentum Entry Alerts - خودرو بانک

Sep 15, 2025

Combining machine learning predictions for LENZ Therapeutics Inc.2025 Trade Ideas & Weekly Top Performers Watchlists - newser.com

Sep 15, 2025

Momentum divergence signals in LENZ Therapeutics Inc. chartQuarterly Earnings Summary & Free Accurate Trade Setup Notifications - newser.com

Sep 15, 2025

Sep 14, 2025

Chart based analysis of LENZ Therapeutics Inc. trendsPortfolio Risk Report & Reliable Price Action Trade Plans - newser.com

Sep 14, 2025

Published on: 2025-09-14 14:02:25 - newser.com

Sep 14, 2025

Intraday pattern recognizer results for LENZ Therapeutics Inc.Sell Signal & AI Powered Market Entry Strategies - newser.com

Sep 14, 2025

Sep 11, 2025

Adage Capital Partners GP L.L.C. Makes New Investment in LENZ Therapeutics, Inc. $LENZ - MarketBeat

Sep 11, 2025

Chevallard Brings Financial Clarity to LENZ Therapeutics - San Diego Business Journal

Sep 11, 2025

Sep 10, 2025